Chou Yung-Chih, Fan Kang-Hsing, Lin Chien-Yu, Hung Tsung-Min, Huang Bing-Shen, Chang Kai-Ping, Kang Chung-Jan, Huang Shiang-Fu, Chang Po-Hung, Hsu Cheng-Lung, Wang Hung-Ming, Hsieh Jason Chia-Hsun, Cheng Ann-Joy, Chang Joseph Tung-Chieh
Proton and Radiation Therapy Center, Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan 333, Taiwan.
Department of Radiation Oncology, New Taipei Municipal Tucheng Hospital, New Taipei City 236, Taiwan.
Cancers (Basel). 2021 Jul 16;13(14):3555. doi: 10.3390/cancers13143555.
(1) Background: We compared the outcomes of patients with nasopharyngeal carcinoma treated with IMPT and VMAT. (2) Methods: We performed a retrospective propensity score matching analysis (1:1) of patients treated with IMPT (years: 2016-2018) and VMAT (2014-2018). Survival was estimated using the Kaplan-Meier method. Multivariate Cox proportional hazards regression analysis was used to identify the independent predictors of survival. Binary toxicity endpoint analyses were performed using a Cox model and logistic regression. (3) Results: Eighty patients who received IMPT and VMAT were included. The median follow-up time was 24.1 months in the IMPT group. Progression-free survival (PFS) and overall survival (OS) were not statistically different between the two groups but potentially better in IMPT group. In multivariate analysis, advanced N-stage and body weight loss (BWL; >7%) during radiotherapy were associated with decreased PFS. The IMPT group had significantly less requirement for nasogastric (NG) tube placement and BWL during treatment. The mean oral cavity dose was the only predictive factor in stepwise regression analysis, and IMPT required a significantly lower mean dose. However, IMPT increased the grade 3 radiation dermatitis. (4) Conclusions: IMPT is associated with reduced rates of NG tube insertion and BWL through reducing oral mean dose, potentially producing better oncologic outcomes.
(1) 背景:我们比较了接受调强质子治疗(IMPT)和容积调强弧形放疗(VMAT)的鼻咽癌患者的治疗结果。(2) 方法:我们对接受IMPT(年份:2016 - 2018年)和VMAT(2014 - 2018年)治疗的患者进行了回顾性倾向评分匹配分析(1:1)。采用Kaplan-Meier法估计生存率。使用多变量Cox比例风险回归分析来确定生存的独立预测因素。使用Cox模型和逻辑回归进行二元毒性终点分析。(3) 结果:纳入了80例接受IMPT和VMAT治疗的患者。IMPT组的中位随访时间为24.1个月。两组之间的无进展生存期(PFS)和总生存期(OS)在统计学上无差异,但IMPT组可能更好。在多变量分析中,晚期N分期和放疗期间体重减轻(BWL;>7%)与PFS降低相关。IMPT组在治疗期间鼻胃管放置需求和BWL明显更少。口腔平均剂量是逐步回归分析中的唯一预测因素,且IMPT所需的平均剂量明显更低。然而,IMPT增加了3级放射性皮炎的发生率。(4) 结论:IMPT通过降低口腔平均剂量,与鼻胃管插入率和BWL降低相关,可能产生更好的肿瘤学结果。